Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Baseline Tumor Size and Survival Outcomes among Patients with Advanced NSCLC treated with First-Line Immunotherapy

Y. Uehara, T. Hakozaki, R. Kitadai, Y. Hosomi

Journal of Thoracic Oncology（2022）

Cited 0|Views1
No score
Abstract
The baseline tumor size (BTS) is known as a prognostic of overall survival (OS) in patients with non-small cell lung cancer (NSCLC) who received immune checkpoint inhibitor monotherapy (ICI-mono). However, prognostic impact of BTS among patients treated with ICI in combination with chemotherapy (ICI-chemo) has not been well investigated.
More
Translated text
Key words
Predictive,Immune checkpoint inhibitor (ICI),Baseline tumor burden
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined